North America Injectable Anticoagulants Industry Market Research Report

June 2017 | 134 pages | ID: N2CE2026FB4EN
Maia Research

Abstracts

Based on the Injectable Anticoagulants industrial chain, this report mainly elaborate the definition, types, applications and major players of Injectable Anticoagulants market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Injectable Anticoagulants market.


The Injectable Anticoagulants market can be split based on product types, major applications, and important regions as follows

Major Players in Injectable Anticoagulants market are:

Sanofi
Aspen
The Medicines Company
Pfizer
Boehringer Ingelheim
Genentech (Roche)
Otsuka

Major Regions play vital role in Injectable Anticoagulants market are:

USA
Canada
Mexico

Most important types of Injectable Anticoagulants products covered in this report are:

Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other

Most widely used downstream fields of Injectable Anticoagulants market covered in this report are:

VTE
ACS/MI
AF
Other

Contents

1 INJECTABLE ANTICOAGULANTS INTRODUCTION AND MARKET OVERVIEW

1.1 Objectives of the Study
1.2 Definition of Injectable Anticoagulants
1.3 Injectable Anticoagulants Market Scope and Market Size Estimation
  1.3.1 Market Concentration Ratio and Market Maturity Analysis
  1.3.2 North America Injectable Anticoagulants Value ($) and Growth Rate from 2012-2022
1.4 Market Segmentation
  1.4.1 Types of Injectable Anticoagulants
  1.4.2 Applications of Injectable Anticoagulants
  1.4.3 Research Regions
    1.4.3.1 USA Injectable Anticoagulants Production Value ($) and Growth Rate (2012-2017)
    1.4.3.2 Canada Injectable Anticoagulants Production Value ($) and Growth Rate (2012-2017)
    1.4.3.3 Mexico Injectable Anticoagulants Production Value ($) and Growth Rate (2012-2017)
1.5 Market Dynamics
  1.5.1 Drivers
    1.5.1.1 Emerging Countries of Injectable Anticoagulants
    1.5.1.2 Growing Market of Injectable Anticoagulants
  1.5.2 Limitations
  1.5.3 Opportunities
1.6 Industry News and Policies by Regions
  1.6.1 Industry News
  1.6.2 Industry Policies

2 INDUSTRY CHAIN ANALYSIS

2.1 Upstream Raw Material Suppliers of Injectable Anticoagulants Analysis
2.2 Major Players of Injectable Anticoagulants
  2.2.1 Major Players Manufacturing Base and Market Share of Injectable Anticoagulants in 2016
  2.2.2 Major Players Product Types in 2016
2.3 Injectable Anticoagulants Manufacturing Cost Structure Analysis
  2.3.1 Production Process Analysis
  2.3.2 Manufacturing Cost Structure of Injectable Anticoagulants
  2.3.3 Raw Material Cost of Injectable Anticoagulants
  2.3.4 Labor Cost of Injectable Anticoagulants
2.4 Market Channel Analysis of Injectable Anticoagulants
2.5 Major Downstream Buyers of Injectable Anticoagulants Analysis

3 NORTH AMERICA INJECTABLE ANTICOAGULANTS MARKET, BY TYPE

3.1 Analysis of Market Status and Feature by Type
3.2 North America Injectable Anticoagulants Value ($) and Market Share by Type (2012-2017)
3.3 North America Injectable Anticoagulants Production and Market Share by Type (2012-2017)
3.4 North America Injectable Anticoagulants Value ($) and Growth Rate by Type (2012-2017)
3.5 North America Injectable Anticoagulants Price Analysis by Type (2012-2017)

4 INJECTABLE ANTICOAGULANTS MARKET, BY APPLICATION

4.1 Downstream Market Overview
4.2 North America Injectable Anticoagulants Consumption and Market Share by Application (2012-2017)
4.3 Downstream Buyers by Application
4.4 North America Injectable Anticoagulants Consumption and Growth Rate by Application (2012-2017)

5 NORTH AMERICA INJECTABLE ANTICOAGULANTS PRODUCTION, VALUE ($) BY REGION (2012-2017)

5.1 North America Injectable Anticoagulants Value ($) and Market Share by Region (2012-2017)
5.2 North America Injectable Anticoagulants Production and Market Share by Region (2012-2017)
5.3 North America Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)
5.4 USA Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)
5.5 Canada Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)
5.6 Mexico Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)

6 NORTH AMERICA INJECTABLE ANTICOAGULANTS SUPPLY PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

6.1 North America Injectable Anticoagulants Consumption by Regions (2012-2017)
6.2 USA Injectable Anticoagulants Production, Consumption, Export, Import (2012-2017)
6.3 Canada Injectable Anticoagulants Production, Consumption, Export, Import (2012-2017)
6.4 Mexico Injectable Anticoagulants Production, Consumption, Export, Import (2012-2017)

7 NORTH AMERICA INJECTABLE ANTICOAGULANTS MARKET STATUS AND SWOT ANALYSIS BY REGIONS

7.1 USA Injectable Anticoagulants Market Status and SWOT Analysis
7.2 Canada Injectable Anticoagulants Market Status and SWOT Analysis
7.3 Mexico Injectable Anticoagulants Market Status and SWOT Analysis

8 COMPETITIVE LANDSCAPE

8.1 Competitive Profile
8.2 Sanofi
  8.2.1 Company Profiles
  8.2.2 Injectable Anticoagulants Product Introduction and Market Positioning
    8.2.2.1 Product Introduction
    8.2.2.2 Market Positioning and Target Customers
  8.2.3 Sanofi Production, Value ($), Price, Gross Margin 2012-2017E
  8.2.4 Sanofi Market Share of Injectable Anticoagulants Segmented by Region in 2016
8.3 Aspen
  8.3.1 Company Profiles
  8.3.2 Injectable Anticoagulants Product Introduction and Market Positioning
    8.3.2.1 Product Introduction
    8.3.2.2 Market Positioning and Target Customers
  8.3.3 Aspen Production, Value ($), Price, Gross Margin 2012-2017E
  8.3.4 Aspen Market Share of Injectable Anticoagulants Segmented by Region in 2016
8.4 The Medicines Company
  8.4.1 Company Profiles
  8.4.2 Injectable Anticoagulants Product Introduction and Market Positioning
    8.4.2.1 Product Introduction
    8.4.2.2 Market Positioning and Target Customers
  8.4.3 The Medicines Company Production, Value ($), Price, Gross Margin 2012-2017E
  8.4.4 The Medicines Company Market Share of Injectable Anticoagulants Segmented by Region in 2016
8.5 Pfizer
  8.5.1 Company Profiles
  8.5.2 Injectable Anticoagulants Product Introduction and Market Positioning
    8.5.2.1 Product Introduction
    8.5.2.2 Market Positioning and Target Customers
  8.5.3 Pfizer Production, Value ($), Price, Gross Margin 2012-2017E
  8.5.4 Pfizer Market Share of Injectable Anticoagulants Segmented by Region in 2016
8.6 Boehringer Ingelheim
  8.6.1 Company Profiles
  8.6.2 Injectable Anticoagulants Product Introduction and Market Positioning
    8.6.2.1 Product Introduction
    8.6.2.2 Market Positioning and Target Customers
  8.6.3 Boehringer Ingelheim Production, Value ($), Price, Gross Margin 2012-2017E
  8.6.4 Boehringer Ingelheim Market Share of Injectable Anticoagulants Segmented by Region in 2016
8.7 Genentech (Roche)
  8.7.1 Company Profiles
  8.7.2 Injectable Anticoagulants Product Introduction and Market Positioning
    8.7.2.1 Product Introduction
    8.7.2.2 Market Positioning and Target Customers
  8.7.3 Genentech (Roche) Production, Value ($), Price, Gross Margin 2012-2017E
  8.7.4 Genentech (Roche) Market Share of Injectable Anticoagulants Segmented by Region in 2016
8.8 Otsuka
  8.8.1 Company Profiles
  8.8.2 Injectable Anticoagulants Product Introduction and Market Positioning
    8.8.2.1 Product Introduction
    8.8.2.2 Market Positioning and Target Customers
  8.8.3 Otsuka Production, Value ($), Price, Gross Margin 2012-2017E
  8.8.4 Otsuka Market Share of Injectable Anticoagulants Segmented by Region in 2016

9 NORTH AMERICA INJECTABLE ANTICOAGULANTS MARKET ANALYSIS AND FORECAST BY TYPE AND APPLICATION

9.1 North America Injectable Anticoagulants Market Value ($) & Volume Forecast, by Type (2017-2022)
  9.1.1 Low-molecular-weight Heparin (LMWH) Market Value ($) and Volume Forecast (2017-2022)
  9.1.2 Direct Thrombin Inhibitor (DTI) Market Value ($) and Volume Forecast (2017-2022)
  9.1.3 Other Market Value ($) and Volume Forecast (2017-2022)
9.2 North America Injectable Anticoagulants Market Value ($) & Volume Forecast, by Application (2017-2022)
  9.2.1 VTE Market Value ($) and Volume Forecast (2017-2022)
  9.2.2 ACS/MI Market Value ($) and Volume Forecast (2017-2022)
  9.2.3 AF Market Value ($) and Volume Forecast (2017-2022)
  9.2.4 Other Market Value ($) and Volume Forecast (2017-2022)

10 INJECTABLE ANTICOAGULANTS MARKET ANALYSIS AND FORECAST BY REGION

10.1 USA Market Value ($) and Consumption Forecast (2017-2022)
10.2 Canada Market Value ($) and Consumption Forecast (2017-2022)
10.3 Mexico Market Value ($) and Consumption Forecast (2017-2022)

11 NEW PROJECT FEASIBILITY ANALYSIS

11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 RESEARCH FINDING AND CONCLUSION

13 APPENDIX

13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Injectable Anticoagulants
Table Product Specification of Injectable Anticoagulants
Figure Market Concentration Ratio and Market Maturity Analysis of Injectable Anticoagulants
Figure North America Injectable Anticoagulants Value ($) and Growth Rate from 2012-2022
Table Different Types of Injectable Anticoagulants
Figure North America Injectable Anticoagulants Value ($) Segment by Type from 2012-2022
Figure Low-molecular-weight Heparin (LMWH) Picture
Figure Direct Thrombin Inhibitor (DTI) Picture
Figure Other Picture
Table Different Applications of Injectable Anticoagulants
Figure North America Injectable Anticoagulants Value ($) Segment by Applications from 2012-2022
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Table Research Regions of Injectable Anticoagulants
Figure USA Injectable Anticoagulants Production Value ($) and Growth Rate (2012-2017)
Figure Canada Injectable Anticoagulants Production Value ($) and Growth Rate (2012-2017)
Table Mexico Injectable Anticoagulants Production Value ($) and Growth Rate (2012-2017)
Table Emerging Countries of Injectable Anticoagulants
Table Growing Market of Injectable Anticoagulants
Figure Industry Chain Analysis of Injectable Anticoagulants
Table Upstream Raw Material Suppliers of Injectable Anticoagulants with Contact Information
Table Major Players Manufacturing Base and Market Share ($) of Injectable Anticoagulants in 2016
Table Major Players Injectable Anticoagulants Product Types in 2016
Figure Production Process of Injectable Anticoagulants
Figure Manufacturing Cost Structure of Injectable Anticoagulants
Figure Channel Status of Injectable Anticoagulants
Table Major Distributors of Injectable Anticoagulants with Contact Information
Table Major Downstream Buyers of Injectable Anticoagulants with Contact Information
Table Analysis of Market Status and Feature by Type
Table North America Injectable Anticoagulants Value ($) by Type (2012-2017)
Table North America Injectable Anticoagulants Value ($) Share by Type (2012-2017)
Figure North America Injectable Anticoagulants Value ($) Share by Type (2012-2017)
Table North America Injectable Anticoagulants Production by Type (2012-2017)
Table North America Injectable Anticoagulants Production Share by Type (2012-2017)
Figure North America Injectable Anticoagulants Production Share by Type (2012-2017)
Figure North America Injectable Anticoagulants Value ($) and Growth Rate of Low-molecular-weight Heparin (LMWH)
Figure North America Injectable Anticoagulants Value ($) and Growth Rate of Direct Thrombin Inhibitor (DTI)
Figure North America Injectable Anticoagulants Value ($) and Growth Rate of Other
Table North America Injectable Anticoagulants Price by Type (2012-2017)
Figure Downstream Market Overview
Table North America Injectable Anticoagulants Consumption by Application (2012-2017)
Table North America Injectable Anticoagulants Consumption Market Share by Application (2012-2017)
Figure North America Injectable Anticoagulants Consumption Market Share by Application (2012-2017)
Table Downstream Buyers Introduction by Application
Figure North America Injectable Anticoagulants Consumption and Growth Rate of VTE (2012-2017)
Figure North America Injectable Anticoagulants Consumption and Growth Rate of ACS/MI (2012-2017)
Figure North America Injectable Anticoagulants Consumption and Growth Rate of AF (2012-2017)
Figure North America Injectable Anticoagulants Consumption and Growth Rate of Other (2012-2017)
Table North America Injectable Anticoagulants Value ($) by Region (2012-2017)
Table North America Injectable Anticoagulants Value ($) Market Share by Region (2012-2017)
Figure North America Injectable Anticoagulants Value ($) Market Share by Region (2012-2017)
Table North America Injectable Anticoagulants Production by Region (2012-2017)
Table North America Injectable Anticoagulants Production Market Share by Region (2012-2017)
Figure North America Injectable Anticoagulants Production Market Share by Region (2012-2017)
Table North America Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)
Table USA Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)
Table Canada Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)
Table Mexico Injectable Anticoagulants Production, Value ($), Price and Gross Margin (2012-2017)
Table North America Injectable Anticoagulants Consumption by Regions (2012-2017)
Figure North America Injectable Anticoagulants Consumption Share by Regions (2012-2017)
Table USA Injectable Anticoagulants Production, Consumption, Export, Import (2012-2017)
Table Canada Injectable Anticoagulants Production, Consumption, Export, Import (2012-2017)
Table Mexico Injectable Anticoagulants Production, Consumption, Export, Import (2012-2017)
Figure USA Injectable Anticoagulants Production and Growth Rate Analysis
Figure USA Injectable Anticoagulants Consumption and Growth Rate Analysis
Figure USA Injectable Anticoagulants SWOT Analysis
Figure Canada Injectable Anticoagulants Production and Growth Rate Analysis
Figure Canada Injectable Anticoagulants Consumption and Growth Rate Analysis
Figure Canada Injectable Anticoagulants SWOT Analysis
Figure Mexico Injectable Anticoagulants Production and Growth Rate Analysis
Figure Mexico Injectable Anticoagulants Consumption and Growth Rate Analysis
Figure Mexico Injectable Anticoagulants SWOT Analysis
Figure Competitive Matrix and Pattern Characteristics of Injectable Anticoagulants Market
Figure Top 3 Market Share of Injectable Anticoagulants Companies
Figure Top 6 Market Share of Injectable Anticoagulants Companies
Table Mergers, Acquisitions and Expansion Analysis
?Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Sanofi Production, Value ($), Price, Gross Margin 2012-2017E
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2012-2017E
Figure Sanofi Market Share of Injectable Anticoagulants Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Aspen Production, Value ($), Price, Gross Margin 2012-2017E
Figure Aspen Production and Growth Rate
Figure Aspen Value ($) Market Share 2012-2017E
Figure Aspen Market Share of Injectable Anticoagulants Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table The Medicines Company Production, Value ($), Price, Gross Margin 2012-2017E
Figure The Medicines Company Production and Growth Rate
Figure The Medicines Company Value ($) Market Share 2012-2017E
Figure The Medicines Company Market Share of Injectable Anticoagulants Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Pfizer Production, Value ($), Price, Gross Margin 2012-2017E
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2012-2017E
Figure Pfizer Market Share of Injectable Anticoagulants Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Boehringer Ingelheim Production, Value ($), Price, Gross Margin 2012-2017E
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2012-2017E
Figure Boehringer Ingelheim Market Share of Injectable Anticoagulants Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Genentech (Roche) Production, Value ($), Price, Gross Margin 2012-2017E
Figure Genentech (Roche) Production and Growth Rate
Figure Genentech (Roche) Value ($) Market Share 2012-2017E
Figure Genentech (Roche) Market Share of Injectable Anticoagulants Segmented by Region in 2016
Table Company Profiles
Table Product Introduction
Table Market Positioning and Target Customers
Table Otsuka Production, Value ($), Price, Gross Margin 2012-2017E
Figure Otsuka Production and Growth Rate
Figure Otsuka Value ($) Market Share 2012-2017E
Figure Otsuka Market Share of Injectable Anticoagulants Segmented by Region in 2016
Table North America Injectable Anticoagulants Market Value ($) Forecast, by Type
Table North America Injectable Anticoagulants Market Volume Forecast, by Type
?Figure North America Injectable Anticoagulants Market Value ($) and Growth Rate Forecast of Low-molecular-weight Heparin (LMWH) (2017-2022)
Figure North America Injectable Anticoagulants Market Volume and Growth Rate Forecast of Low-molecular-weight Heparin (LMWH) (2017-2022)
Figure North America Injectable Anticoagulants Market Value ($) and Growth Rate Forecast of Direct Thrombin Inhibitor (DTI) (2017-2022)
Figure North America Injectable Anticoagulants Market Volume and Growth Rate Forecast of Direct Thrombin Inhibitor (DTI) (2017-2022)
Figure North America Injectable Anticoagulants Market Value ($) and Growth Rate Forecast of Other (2017-2022)
Figure North America Injectable Anticoagulants Market Volume and Growth Rate Forecast of Other (2017-2022)
Table North America Market Value ($) Forecast by Application (2017-2022)
Table North America Market Volume Forecast by Application (2017-2022)
Figure North America Injectable Anticoagulants Consumption and Growth Rate of VTE (2012-2017)
Figure North America Injectable Anticoagulants Consumption and Growth Rate of ACS/MI (2012-2017)
Figure North America Injectable Anticoagulants Consumption and Growth Rate of AF (2012-2017)
Figure North America Injectable Anticoagulants Consumption and Growth Rate of Other (2012-2017)
Figure Market Value ($) and Growth Rate Forecast of Other (2017-2022)
Figure Market Volume and Growth Rate Forecast of Other (2017-2022)
Figure USA Market Value ($) and Growth Rate Forecast (2017-2022)
Table USA Consumption and Growth Rate Forecast (2017-2022)
Figure Canada Market Value ($) and Growth Rate Forecast (2017-2022)
Table Canada Consumption and Growth Rate Forecast (2017-2022)
Figure Mexico Market Value ($) and Growth Rate Forecast (2017-2022)
Table Mexico Consumption and Growth Rate Forecast (2017-2022)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery